c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Castle Biosciences CEO Maetzold sells $464,870 in shares
Investing.com | Nov 15, 2026 8:01 PM EST
Read original article